News Story: Full Text
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Phase II Trial Demonstrates Benefit for Patients With Recurrent Meningiomas

Al's Comment:

 We have not heard any advances with meningioma treatments in a while.  There was no comparison group so it is hard to tell how good it did, but both drugs are already readily available off label so this is already an option for people with aggressive and recurrent meningiomas.


Posted on: 02/01/2020

Phase II Trial Demonstrates Benefit for Patients With Recurrent Meningiomas

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740